after treatment with 1-beta-d-arabino-furanosylcytosine ( ara-c ) , much more aractp as well as aracdp-choline was formed in lymphoma cells than in lymphocytes explaining the high sensitivity of lymphoma cells to this drug .
C0024264
lymphocytes
C0024299
lymphoma